These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 6268649

  • 21. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
    Palumbo PE, Arvin AM, Koropchak CM, Wittek AE.
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2141-7. PubMed ID: 6096492
    [Abstract] [Full Text] [Related]

  • 22. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
    Brunell PA, Novelli VM, Keller PM, Ellis RW.
    J Infect Dis; 1987 Sep; 156(3):430-5. PubMed ID: 3039010
    [Abstract] [Full Text] [Related]

  • 23. Complement-enhanced neutralizing antibody response to varicella-zoster virus.
    Grose C, Edmond BJ, Brunell PA.
    J Infect Dis; 1979 Apr; 139(4):432-7. PubMed ID: 220336
    [Abstract] [Full Text] [Related]

  • 24. The potency determination of human varicella-zoster immunoglobulin by enzyme-linked immunosorbent assay, complement-fixation test and indirect fluorescent antibody tests.
    Winsnes R, Wiger D.
    J Biol Stand; 1986 Oct; 14(4):351-61. PubMed ID: 3031076
    [Abstract] [Full Text] [Related]

  • 25. Differences in antibody responses in varicella, herpes zoster and after vaccination.
    Kimoto T, Kurimura T.
    Arch Virol; 1979 Oct; 59(1-2):59-67. PubMed ID: 218537
    [Abstract] [Full Text] [Related]

  • 26. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test.
    Sauerbrei A, Färber I, Brandstädt A, Schacke M, Wutzler P.
    J Virol Methods; 2004 Jul; 119(1):25-30. PubMed ID: 15109817
    [Abstract] [Full Text] [Related]

  • 27. A method for determining the cut-off value of a varicella-zoster virus IgG enzyme immunoassay for immune status.
    Robertson PW, Bell SM, Ferson MJ.
    J Virol Methods; 1989 Oct; 26(1):115-8. PubMed ID: 2556421
    [Abstract] [Full Text] [Related]

  • 28. Immunity to varicella-zoster virus in a normal adult population.
    Ndumbe PM, Macqueen S, Holzel H, Levinsky RJ.
    J Med Microbiol; 1985 Aug; 20(1):105-11. PubMed ID: 2991523
    [Abstract] [Full Text] [Related]

  • 29. Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin.
    Paryani SG, Arvin AM, Koropchak CM, Dobkin MB, Wittek AE, Amylon MD, Budinger MD.
    J Pediatr; 1984 Aug; 105(2):200-5. PubMed ID: 6086866
    [Abstract] [Full Text] [Related]

  • 30. Neutralizing antibody responses to varicella-zoster virus.
    Schmidt NJ, Lennette EH.
    Infect Immun; 1975 Sep; 12(3):606-13. PubMed ID: 170206
    [Abstract] [Full Text] [Related]

  • 31. Quantitation of antibodies to varicella-zoster virus by immune adherence hemagglutination.
    Wong CL, Castriciano S, Chernesky MA, Rawls WE.
    J Clin Microbiol; 1978 Jan; 7(1):6-11. PubMed ID: 203604
    [Abstract] [Full Text] [Related]

  • 32. Antibodies against varicella-zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections.
    Källander CF, Torfason EG, Olding-Stenkvist E, Sundqvist VA, Diderholm H, Gronowitz JS.
    J Med Virol; 1989 May; 28(1):30-7. PubMed ID: 2542443
    [Abstract] [Full Text] [Related]

  • 33. [Interpretation of varicella serology in pregnancy].
    von Hintzenstern J, Jahn G.
    Geburtshilfe Frauenheilkd; 1988 Dec; 48(12):859-62. PubMed ID: 2853094
    [Abstract] [Full Text] [Related]

  • 34. IgG subclass distribution among antibodies to varicella-zoster virus in human varicella/zoster immunoglobulin preparations and the corresponding donor plasma.
    Møyner K, Michaelsen TE.
    J Biol Stand; 1988 Jul; 16(3):157-64. PubMed ID: 2844824
    [Abstract] [Full Text] [Related]

  • 35. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination.
    Harper DR, Grose C.
    J Infect Dis; 1989 Mar; 159(3):444-51. PubMed ID: 2536788
    [Abstract] [Full Text] [Related]

  • 36. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J, Schmid DS, Gershon AA.
    J Infect Dis; 2008 Mar 01; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [Abstract] [Full Text] [Related]

  • 37. Enzyme-linked immunosorbent assay for susceptibility to varicella.
    Shehab Z, Brunell PA.
    J Infect Dis; 1983 Sep 01; 148(3):472-6. PubMed ID: 6311911
    [Abstract] [Full Text] [Related]

  • 38. Western blot analysis of antibody to varicella-zoster virus.
    Dubey L, Steinberg SP, LaRussa P, Oh P, Gershon AA.
    J Infect Dis; 1988 May 01; 157(5):882-8. PubMed ID: 2834466
    [Abstract] [Full Text] [Related]

  • 39. Antibody avidity following varicella-zoster virus infections.
    Kangro HO, Manzoor S, Harper DR.
    J Med Virol; 1991 Feb 01; 33(2):100-5. PubMed ID: 1646852
    [Abstract] [Full Text] [Related]

  • 40. Varicella zoster virus immunisation.
    Holzel H, Jumaa P.
    Lancet; 1999 Oct 02; 354(9185):1207. PubMed ID: 10513734
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.